(Q46440509)

22 December 2017

title

Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors (English)

1 reference

22 December 2017

1 reference

1

1 reference

22 December 2017

author name string

Ikuko Take

2

1 reference

22 December 2017

Teruhito Yamashita

3

1 reference

22 December 2017

Toshihide Mizoguchi

4

1 reference

22 December 2017

Tadashi Ninomiya

5

1 reference

22 December 2017

Toshimi Hattori

6

1 reference

22 December 2017

Saburo Kurihara

7

1 reference

22 December 2017

Hidehiro Ozawa

8

1 reference

22 December 2017

Nobuyuki Udagawa

9

1 reference

22 December 2017

Naoyuki Takahashi

10

1 reference

22 December 2017

language of work or name

English

0 references

publication date

15 April 2005

1 reference

22 December 2017

Journal of Biological Chemistry

published in

1 reference

22 December 2017

volume

280

1 reference

22 December 2017

issue

25

1 reference

22 December 2017

page(s)

24035-24042

1 reference

22 December 2017

Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Regulation of the differentiation and function of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Modulation of osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Osteoblastic cells are involved in osteoclast formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Genetic regulation of osteoclast development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Genetic and pharmacological analysis of prostanoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Prostaglandin E2 activates outwardly rectifying Cl(-) channels via a cAMP-dependent pathway and reduces cell motility in rat osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

The in vivo anabolic actions of prostaglandins in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Restoration of bone mass in the severely osteopenic senescent rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

An EP2 receptor-selective prostaglandin E 2 agonist induces bone healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

Molecular Pharmacology of the Calcitonin Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M500926200

21 January 2018

Identifiers

DOI

10.1074/JBC.M500926200

1 reference

22 December 2017

1 reference

22 December 2017